We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Pacific Northwest Udall Center (PANUC) Clinical Core (PANUC)

This study is currently recruiting participants.
Verified May 2017 by Cyrus Zabetian, University of Washington
Sponsor:
ClinicalTrials.gov Identifier:
NCT01720810
First Posted: November 2, 2012
Last Update Posted: May 31, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Information provided by (Responsible Party):
Cyrus Zabetian, University of Washington
  Purpose
This study evaluates cognitive impairment in subjects with Parkinson disease (PD) and similar neurological disorder through obtaining longitudinal clinical and neuropsychological data. The long term goal is to have a well-characterized subject population to contribute to our understanding of the natural history, diagnosis and ultimate treatment of cognitive impairment in patients with PD and similar disorders.

Condition
Parkinson Disease Cognitive Impairment

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Pacific Northwest Udall Center (PANUC) Clinical Core

Resource links provided by NLM:


Further study details as provided by Cyrus Zabetian, University of Washington:

Estimated Enrollment: 2000
Study Start Date: March 2010
Estimated Study Completion Date: June 2020
Estimated Primary Completion Date: June 2020 (Final data collection date for primary outcome measure)
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

All subjects undergo the following procedures:

  • Interview to collect data on medical history and demographics
  • Neurological examination
  • Questionnaires about mood, activities of daily living, and environmental exposures.
  • Psychometric tests

Study companions might also be asked to complete questionnaires about the participant's thinking and memory, activities of daily living, sleep, and neuropsychiatric symptoms.

Criteria

Inclusion Criteria:

  • Diagnosis of Parkinson disease
  • Over 18 years of age

Exclusion Criteria:

- Under 18 years of age

  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01720810


Contacts
Contact: Louren Reed (206) 277-5516 louren@uw.edu

Locations
United States, Washington
VA Puget Sound Health Care System Recruiting
Seattle, Washington, United States, 98108
Contact: Louren Reed    206-277-5516    louren@uw.edu   
Principal Investigator: Cyrus P Zabetian, MD, MS         
Sponsors and Collaborators
University of Washington
  More Information

Responsible Party: Cyrus Zabetian, Associate Professor, Neurology, University of Washington
ClinicalTrials.gov Identifier: NCT01720810     History of Changes
Other Study ID Numbers: 37855
First Submitted: October 31, 2012
First Posted: November 2, 2012
Last Update Posted: May 31, 2017
Last Verified: May 2017

Additional relevant MeSH terms:
Parkinson Disease
Cognition Disorders
Parkinsonian Disorders
Basal Ganglia Diseases
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Movement Disorders
Neurodegenerative Diseases
Neurocognitive Disorders
Mental Disorders